CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 1,710 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 856 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 5,452 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,453 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 890 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 4 Open-market sale Director sold 21,959 shares at $16.15 ($354,638)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 28,357 shares at $15.18 ($430,459)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 52 shares (to pay taxes)
Page 23 of 39 · 778 filings